Serological characterization of human cell surface phenotypes through typing of cultured cell panels and tissues with monoclonal antibodies (mAb) 1 has revealed a high degree of antigenic diversity on somatic cells. Expression of a large number of antigenic systems has been correlated with differentiation pathways (providing markers for cell lineages or distinct stages within a differentiation pathway), with growth characteristics and cell proliferation, or with the transformed phenotype of tumor cells (1) (2) (3) (4) . Coordinate expression of a series of surface antigenic systems was found to be characteristic for certain differentiated cell types, and a cell type-specific sequence of changes in these antigenic patterns was found to accompany cellular differentiation and maturation steps. These principles were established through serological analysis of normal and malignant cells of hematopoietic origin, and have been extended more recently to other human cell types (2, 5) . While phenotypic variability on the human cell surface has been studied in considerable detail, little is known about the genes coding for most surface antigens and genes involved in coordinating the expression of multiple surface components to generate specific phenotypic patterns.
Somatic cell genetic analysis of antigen expression in rodent-human hybrid cells has provided several types of information concerning genes controlling surface antigens and their interaction and organization in the human genome: (a) chromosomal assignment of genes coding for surface antigens (6) ; (b) identification of subunit components of multimeric antigens coded for by different chromosomes (7) (8) (9) ; and (c) definition of regulatory controls of antigen expression related to cell lineage and growth characteristics, including the permis-sive/nonpermissive and the inducing/noninducing character of differentiated rodent cells for the expression of human differentiation antigens (8) .
In this study, we describe the analysis of eight distinct antigenic systems controlled by human chromosome 11, including the putative human Thy-1 antigen, K117 (25 kilodalton [kD] glycoprotein), and T43 (85 kD glycoprotein), a marker of malignant tumors derived from T43-epithelia (4). Our results, and those described by others (10, 11) indicate that a large number of known gene loci coding for cell surface components are clustered in human chromosome 11, and that this chromosome carries several genes differentially expressed on cells undergoing hematopoietic and neuroectodermal differentiation.
Materials and Methods
Cell Lines. 19 mouse-human hybrid clones were derived in the laboratory of X. Breakefield (Yale University, New Haven, CT), from fusions between SK-N-BE(2) human neuroblastoma cells and N4TG-1 mouse neuroblastoma cells (NSK hybrid series), or between BE(2)-C human neuroblastoma cells and NS20TG11E mouse neuroblastoma cells (NBE hybrid series) as described (12) . Additional hybrid cell lines derived from fusions between human melanoma (LC and CE hybrid series) or normal kidney epithelial cells (LNK, ANK, and RC hybrid series) with mouse RAG, A9, or L cells, or with YH21 Chinese hamster ovary cells, have been described (12) (13) (14) . SK-N-MC human neuroblastoma cells were fused with mouse L cells to generate the LMC hybrid series.
Chromosome Analysis of Hybrid Cells. The presence of human genetic material in hybrid cell lines was determined by four methods: (a) Isozyme analysis (enzymes listed in 12). (b) Karyotype analysis; metaphase spreads were stained by trypsin-Giemsa techniques (15, 16) , or by the G11 method (17) , or sequentially with both techniques. ~>25 metaphases were evaluated for each NSK, CE, and LC hybrid, and 10-25 metaphases for NBE hybrids. (c) Cell surface markers; hybrid cells were tested in mixed hemadsorption assays (MHA) (see below) with mAb directed against 21 chromosomally mapped cell surface antigens (8, (12) (13) (14) . (d) Southern blot analysis; presence of the distal end of the short arm of chromosome 11 was confirmed by DNA hybridization techniques with the pT22 (HRAS1) and p/3pstd (/3-globin) probes, obtained from M. Wigler (Columbia University College of Physicians and Surgeons, New York) and T. Maniatis (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY), respectively, using standard procedures, as described (18) . mAb and Serological Procedures. mAb AbG344, AbK117, AbMC139, and AbNP13 were newly derived from mice immunized with cultured human astrocytoma (AbG344, AbK 117), or neuroblastoma cells (AbMC 139), or from a tissue extract (AbNP 13), following standard fusion, hybrid selection, and cloning procedures (19) . The derivation of the other antibodies has been described (4, 5, 8, 19) . MHA rosetting for the detection of surface antigens on cultured cells have been described (5, 12, 19) .
Immunohistochemical Procedures. Tissues were quick-frozen in isopentane precooled in liquid nitrogen. Frozen 5-#m sections were cut, mounted on gelatin-coated slides, airdried, and fixed in cold acetone. Avidin-biotin immunoperoxidase tests were carried out as described (20) , using biotinylated horse anti-mouse IgG (Vector Labs, Burlington, CA) as second antibody.
Immunochemical Procedures. Cells were metabolically labeled with [~SS]methionine or [3H]glucosamine (New England Nuclear, Boston, MA), and used for immunoprecipitation experiments following published procedures (19) .
Results

Serological and Biochemical Characteristics of Cell Surface Antigenic Systems.
Eight antigenic systems defined by mouse mAb are analyzed in this study, including four antigens (K117, MC139, G344, and NP13) detected by newly derived antibodies. T h e antigenic systems can be distinguished by three criteria: (a) differential expression on a cultured h u m a n cell panel, (b) biochemical properties, and (c) differential expression on a panel of reduced r o d e n t -h u m a n somatic cell hybrids. K117 Antigenic System. K 117 is a 25 kD glycoprotein (Fig. 1 A) expressed on a small range of cultured cell types. Fig. 2 summarizes the results of typing a panel of 120 h u m a n t u m o r cell lines and short-term cultures of normal cells for K l 1 7 expression. Neuroblastomas, astrocytomas, sarcomas, teratocarcinomas, and fibroblasts are K 117 +, whereas most melanocytic, epithelial, and hematopoietic cell lines tested are K117-. Frozen sections of normal h u m a n tissues were tested for K 117 expression using the avidin-biotin immunoperoxidase method. Strong K117 reactivity was found with neurons, neuropii, and glial cells in both gray matter and white matter of adult cortex and cerebellum (Fig. 3 ). Blood vessels (endothelium, smooth muscle cells) and connective tissue cells were K117 + in all tissues tested. In the liver, hepatocytes and bile ducts were antigen-negative. In fetal thymus, K117 + cells were found in the septi (blood vessels, connective tissue cells); a proportion of thymocytes in the cortical areas was also K117 +, whereas fewer K117 + cells were located in medullary areas (Fig. 3) .
MC139 Antigenic System. MC139 is a 35 kD glycoprotein (Fig. 1A) expressed on a distinct range of cultured h u m a n cells. All normal and malignant cells of n e u r o e c t o d e r m a l origin tested, most sarcomas, choriocarcinomas, and teratocar- Table I illustrates the results o f MHA assays with a series of 13 mouse-human neuroblastoma hybrid clones, and Fig. 4 shows the human chromosome content of the hybrids. For the eight antigenic systems studied, two patterns of reactivity were observed in this hybrid panel: AbJF23, AbG344, AbA124, AbT43, and AbNP13 cotyped and reacted only with the hybrids containing a complete human chromosome 11. In contrast, AbMC139, AbK117, and AbQ14 reacted with hybrids containing one or more copies of either a normal human chromosome 11 or the The segregation of no other human chromosome followed either of these two distinct patterns of reactivity in the hybrid clones. Analysis was then extended to the entire hybrid panel (32 clones) available for study. Patterns of antibody reactivity and distribution of human chromosomes in the hybrid clones were compared separately for each antigenic system. For this purpose, data were collected only from hybrids derived from fusions between antigen-positive human cells, and rodent cells known to be permissive for the expression of the respective antigen (see below). The numbers of hybrid clones showing a discrepancy between antibody reactivity and presence of individual human chromosomes were used as a measure of concordant/discordant segregation, and are presented in Table II . These results show unequivocally that all eight antigens studied cosegregated with human chromosome 11. The presence of no other human chromosome was necessary or sufficient for antigen expression. For Q14 and JF23, these results confirm our previous findings, which had mapped gene loci MSK13 (controlling Q14) and MSK14 (controlling JF23) to human chromosome 11 (8) .
Regional Assignment of Gene Loci on Human Chromosome 11. Presence of identifiable segments of human chromosome 11 (in the absence of normal homologs of this chromosome) in at least 14 hybrid clones (shown in Figs. 4 and 5) has permitted a subregional assignment on chromosome 11 of gene loci controlling antigen expression. Fig. 5 presents results of the serological typing with a discriminating panel of seven hybrid clones, each clone containing a different, unique portion of human chromosome 11. These typing results can be compared with the specific segments of chromosome 11 genetic material present in the hybrids, as determined by serological typing, karyotype analysis, and testing of hybrid cell DNA for the presence of human HBBC and HRAS1 genes (Fig. 6) , which have been mapped to the distal portion of chromosome 1 l p (6).
Five distinct patterns of surface antigen expression could be distinguished on the hybrid panel for the eight antigenic systems. Three pairs of antigens, JF23/G344, A124/T43, and Q14/Kl17 segregate independently, and their patterns of distribution are different from both the NPI 3 and MC139 patterns. NP13 and MC139 show very similar patterns, with only one discrepancy, the NP13-/MC 139 + hybrid clone NBE-K1. These results permit the regional assignment of genes controlling JF23, G344, A124, T43, and NP13 to human chromosome I Ipter-qI3, and genes controlling MC139, QI4, and KII7 to human chromosome 1 lql3-qter (Fig. 7) . Assuming that a minimum number of separate segments of chromosome 11 are present in the hybrid cells, these results suggest a tentative arrangement of the gene loci on chromosome 11 in the order FXGUnE 5. Differential expression of chromosome l 1-controlled human cell surface antigens on a discriminating rodent-human hybrid pane[. Surface antigen expression on hybrid cells is indicated by filled rectangles, no entry indicates lack of antigen expression. Presence of karyotypically defined segments of chromosome 11 is indicated as ml-6. Segment ml, del(11)(pter-ql 3), comprises chromosome 1 lp and the proximal portion of 1 lq; m2 is probably a rearranged m4 marker chromosome, including bands 1 lql 3-1 lq22; m3 is a small marker chromosome possibly derived from chromosome 11; m4 is the marker chromosome, t (11;20) , present in the parental SK-N-BE(2) cells; m5 and m6 comprise the segment l lq13-1 lqter. Hybrid clones NSK-7 and NSK-10 contain no markers karyotypically identified as comprising 11 material, although both contain several rearranged chromosomes with small unidentified chromosomal segments. The human LDH-A isoenzyme is not consistently detectable in human × mouse neuroblastoma hybrids containing a normal human chromosome 11 (N. Dracopoli, unpublished observations), and therefore results are not included here.
SK-N-MC cells (Fig. 8) . No induction was observed for K117, MC139, and QI4 in the hybrids. However, differences were found in the levels of Kl17 and MC139 expression in chromosome l 1-containing hybrids derived from K117+/MC139 + human neuroblastomas (NBE, NSK, and LMC hybrid series) and MC139 + human melanomas (LM and AM series), depending on the cell type of the rodent fusion partner. NBE and NSK hybrids, constructed with mouse neuroblastoma cells, were strong K 117 and MC 139 expressors. In contrast, LMC hybrids, constructed with mouse L cells, showed little or no reactivity with AbK117 and AbMC139, and AM and LM hybrids, also constructed with L cells or A9 cells, showed no reactivity with AbMC139 (Fig. 8) . The finding that seven independently derived LMC hybrid clones showed weak AbK117 reactivity, and five LMC clones showed weak AbMC139 reactivity (rather than a complete absence of the antigens) is significant in the interpretation of these results. It demonstrates that the Kl17 and MC139 coding sequences are present in the hybrid cells, and that regulatory mechanisms characteristic for the rodent fusion partner control antigen expression in the hybrids. Discussion The Thy-1 antigen of mouse thymocytes (21) was one of the first examples of a group of serologically defined cell surface components designated as differentiation antigens (22) . Studies by several investigators (23, 24) have subsequently identified putative rat, human, and canine Thy-1 molecules, mAb Ab390, which detects a 24 kD glycoprotein in human brain extracts, has been reported (25) as recognizing human Thy-1. The reactivity of Ab390 with a panel of 29 human cell lines and a range of normal tissues has been described (25) , and closely resembles the pattern defined for K117 in the more extensive analysis presented here. The molecular masses of the K117 and 390 molecules are also comparable.
Using the immunoperoxidase method, we found that AbK117 shows the same staining pattern in fetal thymus and several other tissues that has been described for F15-42-1, another mAb reported to detect human Thy-1 (26) . Therefore, AbK117 most likely also recognizes human Thy-1. Our finding that the MSK26 gene locus (controlling K117 expression) maps to human chromosome 1 lql3-qter is consistent with this conclusion, since it places human Thy-1 into the same linkage group (including Ioci APOA1, UPS, and ESA4 in man and Apl-1, Ups, and Es-17 in the mouse) that resides on the Thy-l-carrying chromosome 9 in the mouse (27, 28) . The chromosomal assignment of antigens K117, MC139, Q14, and JF23, which show a restricted or intermediate distribution on the cultured human cell pane] and which follow differentiation patterns, permits the analysis of antigen expression in human chromosome 11-containing hybrids constructed with antigen-positive or antigen-negative human cells and rodent cells of distinct differentiation lineages. The results demonstrate different regulatory principles governing surface expression of these antigens in hybrid cells. For K117 and MC139, antigens strongly expressed on human neuroblastomas, we have found that human-mouse neuroblastoma hybrids (NBE and NSK clones) are strong K117 and MC139 expressors (see Fig. 8 ). In contrast, hybrids derived from human neuroblastoma cells and mouse L cells showed little or no K117 and MC139 expression, and hybrids derived from human melanoma cells (MC139+/Kll 7-phenotype) and mouse A9 or L cells were consistently MC139-, suggesting tissuespecific regulation of K117 and MC139 in hybrid cells, determined by the cell type of the rodent fusion partner. Mouse neuroblastoma cells are permissive for K117 and MC139, but mouse A9 and L cell fibroblasts are not. Similar results have been reported for the expression of mouse Thy-t in rodent cells transfected with a cloned mouse Thy-1 gene, with mouse lymphoma and rat neural tumor cells being permissive, and L cells being nonpermissive for Thy-1 (29) . For JF23, we have found that fusion of cells of the JF23-human neuroblastoma line SK-N-MC with mouse L cells results in cells expressingJF23 (Fig. 8) . This inducing phenotype of L cells for JF23 expression resembles the F8 induction described (8) for L cell hybrids containing human chromosome 19, and contrasts with the permissive/noninducing phenotype of L cells for Q14 (8) , confirmed in this study. Among the neuroblastoma hybrids, induction of F8 and JF23 is seen in clones characterized by fibroblastic morphology and increased substrate adhesiveness compared to the human parental cells (LMC and certain NSK hybrid clones) (8) . Typically, cultured human neuroblastoma cells show a neuroblastic morphology, with round cell bodies and neuritic processes, and adhere poorly to the culture flask substratum. However, variant cells with an epithelial or fibroblast-like morphology have been derived from several of the neuroblastoma cell lines (30) . These variants are strongly substrate-adherent and exhibit an F8+/JF23 + surface phenotype. As F8 andJF23 expression seem to be related to the same cellular growth characteristics in both neuroblastoma variants and hybrid cells, these antigens may have a direct role in cell adhesion. Thus, different regulatory principles determining surface antigen expression in hybrid cells have been identified in our analysis. Some human differentiation antigens are tightly controlled by the phenotype of the rodent fusion partner (inducing and permissive/nonpermissive modes of expression; see K117 and MC139, or A0122 and F23 [8] ). Other antigens are controlled by the growth characteristics of the hybrid cells (inducing and conditionally permissive modes of expression; seeJF23 or F8 [8] ). Some antigens show no such regulatory influence (generally permissive and noninducing modes of expression; see Q14). Fundamentally different genetic mechanisms may be involved in the control of these groups of antigens, not only in hybrid cells, but also in human parental cells. The distinctive nature of each of the eight antigens described in this study has been demonstrated by a combination of serological, biochmical, and genetic methods. Using this approach, the antigens can be compared with cell surface antigens previously assigned to human chromosome 11. Antigens K 117, MC 139, T43, Q14, G344, and NP 13 are readily distinguished from previously assigned antigens based on their characteristic distribution, their biochemical characteristics, and their regional assignments on chromosome 11 (see Table III ). The relationship between JF23, A3D8/A 1G3, and F 10.44.2 remains to be established, particularly since AbJF23 recognizes a variable set of glycopeptides in different cell types (Fig. 1) . A124 has biochemical characteristics of a glycolipid, and resembles in this regard and in its wide distribution the W6/34 and E7 antigens (A. Houghton, Memorial Sloan-Kettering Cancer Center, personal communication). However, human erythrocytes are A 124-, E7 +, and W6/34 +, and therefore AbA124 seems to define a new antigenic system. Our results and those described by others (10, 31) show that human chromosome 11 controls the expression of at least 12 cell surface antigens (Table III) . This contrasts with the small number of surface antigens known to be controlled by other human chromosomes (6) . At least two general mechanisms can account for this clustering of assignments for surface antigens defined by mouse mAb: Human chromosome 11 may have an important role in constructing the human cell surface, and may code for a large number of surface antigens. Alternatively, chromosome 11-controlled cell surface components may be particularly immunogenic in mice and therefore be more readily detected by mouse mAb technology than surface components encoded by other human chromosomes.
Considerable attention has been directed recently towards the occurrence of nonrandom chromosome rearrangements in a number of human malignancies, and the possible involvement of gene loci spatially related to chromosome deletions or break points in generating the malignant phenotype (32) . Cellular oncogenes and genes involved in the control of cell proliferation and cellular differentiation have been of particular interest in this regard. Various mechanisms have been proposed (32, 33) that could result in increased expression of these genes, or in the expression of altered gene products, both leading to a disturbance of cellular differentiation or growth control. Nonrandom rearrangements of chromosome 11 have been associated with hematopoietic malignancies, Wihns' tumors, and other cancers. So far, no close association has been found between the regions on chromosome 11 involved in specific rearrangements and any known gene locus, including the HRAS1 protooncogene (34). Therefore, it seems important to define new gene loci on chromosome 11, especially gene loci that are actively transcribed in specific tumor cells, and genes that specify proliferation or transformation-related cellular traits. In addition, gene loci that are closely related to breakpoints may provide markers for further genetic studies, even if they are not involved in disturbances of cellular proliferation or differentiation. Certain antigenic systems described here deserve special attention with regard to the transformed phenotype. A specific translocation, t(11;22) (q24;q12), has been described for Ewing sarcomas (35, 36) ; moreover, Geurts van Kessel et al. (37) have shown that the c-sis oncogene is translocated from chromosome 22 to the rearranged chromosome 11 in a Ewing sarcoma cell line. Conceivably, such a translocation could bring c-sis into the proximity, and possibly under the influence of genes located on chromosome 1 lq. Both MSK25 (controlling MC 139) and MSK26 (controlling K117) map to this region (1 lql 3-qter), and MC 139 and K 117 are expressed at high levels in Ewing sarcoma cells. Therefore, it is important to determine more precisely the localization of these genes relative to the breakpoint region, and to investigate their possible effects on c-sis expression. The translocation of c-myc to the Ig gene cluster provides a precedent for such an interaction (33) , and it may be important that Ig and Thy-1 belong to a common family of related cell surface and secreted glycoproteins (38) . In the case of the T43 antigenic system, it may be significant that we have now mapped MSK23 (controlling T43) to chromosome 11 pter-q 13. Fradet et al. (4) have shown, in an immunohistochemical study of normal and malignant human tissues, that T43 is a marker of malignant tumors derived from T43-epithelia. 15 malignant tumors of bladder, colon, lung, and breast all had a T43 + phenotype, while the corresponding normal epithelia, and nine cases of benign tumors derived from these tissues were T43-(4). It is tempting to speculate that T43 is not only a marker of malignant tumors, but is directly involved in generating the malignant phenotype, and the rearrangements of chromosome 11 may contribute to the malignant behavior of tumor cells by changing the pattern of T43 expression, or through expression of an altered T43 molecule.
Fine mapping of MSK23 on chromosome 11, through serological analysis of somatic cell hybrids, including hybrids constructed with cells from Wilms' tumor patients (34), will be an important next step in this analysis.
Summary
The expression of eight serologically and biochemically distinct human cell surface antigens defined by monoclonal antibodies was examined on a panel of rodent-human somatic cell hybrids. Cosegregation was observed for human chromosome 11, and surface expression of all eight antigens was studied. Serological analysis of hybrids containing defined segments of human chromosome 11 permitted the regional assignment of genes controlling antigens JF23 (90 kD glycoprotein), G344 (25 kD), T43 (85 kD), A124, and NP13 to chromosome 1 lpter-q13, and of genes controlling Q14 (130 kD), MC139 (35 kD), and K117 (25 kD) to chromosome 1 lql3-qter. K117, the putative human Thy-1 antigen, was expressed at high levels in chromosome 11-containing hybrids constructed with mouse neuroblastoma ceils, but showed little or no expression in hybrids constructed with mouse L cells. A similar pattern of expression in hybrids was found for MC 139, an antigen shared by neuroectoderm-derived cells and normal and malignant T lymphocytes. T43 is a marker of malignant tumors (but not benign tumors) derived from a number of T43-epithelia, and the regional assignment of the T43 locus on chromosome 11 raises questions about its possible involvement in the specific rearrangements of this chromosome seen in human malignancies.
